🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Bio-Rad Laboratories, Inc.

BIO Healthcare
$247.53 +$1.26 (0.51%)
Market Cap: $6.62 B
Gurus Holding
10
Popularity Rank
#486
% of Shares Held
16.28%
Net Activity (Q1 2026)
+$6.19 M

Guru Ownership Trend

Guru Analysis for Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories, Inc. (BIO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.08 B.

Top institutional holders include First Eagle Investment and John Rogers.

Institutional sentiment is currently Bullish. This is evidenced by a $6.19 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 135.2%. Conversely, Mason Hawkins reduced exposure by 28.5%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$43.31 M
Total Buy Value
New Buys 2
Additions 5
-$37.12 M
Total Sell Value
Reductions 2
Sold Out 2

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
4
Net Buyers
7

FAQs for Bio-Rad Laboratories, Inc. (BIO)

Major holders include First Eagle Investment ($725.52 M), John Rogers ($219.09 M), First Pacific Advisors ($113.55 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 4.36 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $6.19 M, with 7 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited BIO. The total reported sell value was $37.12 M.

Yes, 2 managers opened new positions in BIO, and 5 increased their existing holdings. The total reported buy value was $43.31 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.96% Add 1.3% 2,602,772 $725.52 M Q1 2026
2.45% Add 2.8% 785,961 $219.09 M Q1 2026
1.59% Add 1.5% 407,358 $113.55 M Q1 2026
2.23% Reduce -28.5% 162,804 $45.38 M Q1 2026
0.13% Add 30.2% 152,384 $42.48 M Q1 2026
0.01% Reduce -9.5% 118,683 $33.08 M Q1 2026
0.01% Add 135.2% 94,549 $26.03 M Q1 2026
0.07% 26,750 $7.46 M Q1 2026
0.00% New Buy 5,161 $1.44 M Q1 2026
0.00% New Buy 1,684 $469,415 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form